{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:59Z","timestamp":1793089079806,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.beem.2026.102081","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:28:31Z","timestamp":1768235311000},"page":"102081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fertility and pregnancy in patients with prolactinoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Matheo A.M.","family":"Stumpf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nara L.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","article-title":"Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility","volume":"94","author":"Souter","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ando.2022.04.002","article-title":"Mild hyperprolactinemia in a couple: What impact on fertility?","volume":"83","author":"Maiter","year":"2022","journal-title":"Ann Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib4","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2026.102081_bib5","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2026.102081_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2026.102081_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11102-019-01010-5","article-title":"Prolactinomas in pregnancy: considerations before conception and during pregnancy","volume":"23","author":"Glezer","year":"2020","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2024.05.004","article-title":"Prolactinomas: preconception and During Pregnancy","volume":"53","author":"Zhang","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/2359-3997000000230","article-title":"Interactions between prolactin and kisspeptin to control reproduction","volume":"60","author":"Donato","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2026.102081_bib11","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1172\/JCI63937","article-title":"Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration","volume":"122","author":"Sonigo","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/js.2017-00328","article-title":"Hypothalamic-pituitary-ovarian axis reactivation by Kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea","volume":"1","author":"Millar","year":"2017","journal-title":"J Endocr Soc"},{"issue":"8","key":"10.1016\/j.beem.2026.102081_bib13","doi-asserted-by":"crossref","first-page":"e3515","DOI":"10.1210\/clinem\/dgac166","article-title":"Kisspeptin overcomes GnRH neuronal suppression secondary to hyperprolactinemia in humans","volume":"107","author":"Hoskova","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib14","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz112","article-title":"Fertility and pregnancy in women with hypopituitarism: a systematic literature review","volume":"105","author":"Vila","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11154-023-09863-9","article-title":"Fertility issues in hypopituitarism","volume":"25","author":"Chen","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/js.2017-00359","article-title":"Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program: a randomized controlled trial","volume":"2","author":"Altm\u00e4e","year":"2018","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.beem.2026.102081_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12121991","article-title":"The effect of human growth hormone on endometrial growth in controlled ovarian hyperstimulation cycles","volume":"12","author":"Bavan","year":"2022","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/er.2006-0022","article-title":"The molecular control of corpus luteum formation, function, and regression","volume":"28","author":"Stocco","year":"2007","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib19","doi-asserted-by":"crossref","first-page":"E676","DOI":"10.1152\/ajpendo.91020.2008","article-title":"Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes","volume":"297","author":"Bachelot","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/rep.0.1210197","article-title":"Potential roles of decidual prolactin in early pregnancy","volume":"121","author":"Jabbour","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.beem.2026.102081_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212736","article-title":"Immunomodulatory role of decidual prolactin on the human fetal membranes and placenta","volume":"14","author":"Flores-Espinosa","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1101\/gad.11.2.167","article-title":"Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse","volume":"11","author":"Ormandy","year":"1997","journal-title":"Genes Dev"},{"issue":"23","key":"10.1016\/j.beem.2026.102081_bib23","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene","volume":"16","author":"Horseman","year":"1997","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.beem.2026.102081_bib24","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1210\/clinem\/dgab201","article-title":"PRL mutation causing alactogenesis: insights into prolactin structure and function relationships","volume":"106","author":"Moriwaki","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.beem.2026.102081_bib25","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1805171","article-title":"Variant prolactin receptor in agalactia and hyperprolactinemia","volume":"379","author":"Kobayashi","year":"2018","journal-title":"N Engl J Med"},{"issue":"5978","key":"10.1016\/j.beem.2026.102081_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bmj.3.5978.274","article-title":"An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea","volume":"3","author":"Glass","year":"1975","journal-title":"Br Med J"},{"issue":"5807","key":"10.1016\/j.beem.2026.102081_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/290600a0","article-title":"Prolactin inhibits oestrogen synthesis in the ovary","volume":"290","author":"Dorrington","year":"1981","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib28","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","article-title":"Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary","volume":"54","author":"Demura","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib29","first-page":"486","article-title":"Prolactin hypersecretion and short luteal phase defects","volume":"47","author":"Corenblum","year":"1976","journal-title":"Obstet Gynecol"},{"issue":"7953","key":"10.1016\/j.beem.2026.102081_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","article-title":"Hyperprolactinaemia and luteal insufficiency","volume":"1","author":"Sepp\u00e4l\u00e4","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.beem.2026.102081_bib32","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa650","article-title":"Predictors of chronic LH-testosterone axis suppression in male macroprolactinomas with normoprolactinemia on cabergoline","volume":"105","author":"Sehemby","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0015-0282(16)44359-1","article-title":"Male hyperprolactinemia:effects on fertility","volume":"32","author":"Segal","year":"1979","journal-title":"Fertil Steril"},{"issue":"1-2","key":"10.1016\/j.beem.2026.102081_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/ENDO:20:1-2:75","article-title":"Hyperprolactinemia in men: clinical and biochemical features and response to treatment","volume":"20","author":"De Rosa","year":"2003","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1439-0272.1992.tb02617.x","article-title":"Hyperprolactinaemia and hyperserotoninaemia: their relationship to seminal quality","volume":"24","author":"Gonzales","year":"1992","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.aju.2017.10.002","article-title":"Hyperprolactinaemia in male infertility: clinical case scenarios","volume":"16","author":"Dabbous","year":"2018","journal-title":"Arab J Urol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11102-023-01313-8","article-title":"How to manage intolerance to dopamine agonist in patients with prolactinoma","volume":"26","author":"Stumpf","year":"2023","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos Nunes","year":"2011","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12020-025-04215-w","article-title":"Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study","volume":"89","author":"Rudman","year":"2025","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s11102-022-01259-3","article-title":"Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma","volume":"25","author":"Rudman","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102081_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/bs.vh.2024.11.001","article-title":"Hypogonadism in men with prolactinoma: diagnosis, treatment, and management of persistent hypogonadism","volume":"129","author":"Rudman","year":"2025","journal-title":"Vitam Horm"},{"key":"10.1016\/j.beem.2026.102081_bib43","article-title":"Approach to the patient with dopamine-resistant microprolactinoma","author":"Glezer","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0037-1615748","article-title":"Comparison of male and female prolactinoma patients requiring surgical intervention","volume":"79","author":"Yoo","year":"2018","journal-title":"J Neurol Surg B Skull Base"},{"issue":"7","key":"10.1016\/j.beem.2026.102081_bib45","first-page":"2102","article-title":"Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study","volume":"82","author":"Delgrange","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib46","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","article-title":"Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis","volume":"89","author":"Colao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2026.102081_bib47","first-page":"1077","article-title":"Experience in the treatment of male prolactinomas: a single-center, 10-year retrospective study","volume":"114","author":"Ke","year":"2024","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03349742","article-title":"Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma)","volume":"18","author":"Berezin","year":"1995","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMcp2311150","article-title":"Infertility evaluation and treatment","volume":"392","author":"Santoro","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1993.tb02372.x","article-title":"The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group","volume":"39","author":"Webster","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"14","key":"10.1016\/j.beem.2026.102081_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib53","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy","volume":"86","author":"Di Sarno","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib54","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":"Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00667386","article-title":"Prolactin oversuppression","volume":"223","author":"Bohnet","year":"1977","journal-title":"Arch Gynakol"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9378(78)90753-6","article-title":"Pattern of sexual steroids, prolactin, and gonadotropic hormones during prolactin inhibition in normally cycling women","volume":"132","author":"Schulz","year":"1978","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s11102-022-01242-y","article-title":"Proportion and predictors of hypogonadism recovery in men with macroprolactinomas treated with dopamine agonists","volume":"25","author":"Al Dahmani","year":"2022","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11102-024-01445-5","article-title":"Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists","volume":"27","author":"Constantinescu","year":"2024","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102081_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2016.04.009","article-title":"Spermatogenesis in humans and its affecting factors","volume":"59","author":"Neto","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"3563","key":"10.1016\/j.beem.2026.102081_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.140.3563.184","article-title":"Spermatogenesis in man: an estimate of its duration","volume":"140","author":"Heller","year":"1963","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.2006.02461.x","article-title":"The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males","volume":"64","author":"De Rosa","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11102-005-5084-3","article-title":"PRL secreting adenomas in male patients","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-21-0561","article-title":"Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline","volume":"185","author":"Biagetti","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102081_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1664621","article-title":"Prolactin secreting pituitary neuroendocrine tumors treated by dopamine agonists: predictors of response","volume":"16","author":"Mele","year":"2025","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-025-01512-5","article-title":"Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas","volume":"28","author":"Bostan","year":"2025","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2026.102081_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102919","article-title":"Efficacy and safety of endoscopic transsphenoidal resection for prolactinoma: a retrospective multicenter case-series","volume":"54","author":"Zandbergen","year":"2023","journal-title":"Arch Med Res"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041089","article-title":"A narrative review of surgery for prolactinomas: considerations and controversies","volume":"14","author":"Mann","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.beem.2026.102081_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clineuro.2018.11.024","article-title":"Fertility after transsphenoidal surgery in patients with prolactinomas: a meta-analysis","volume":"176","author":"Lamba","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib70","first-page":"21557","article-title":"Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period","volume":"8","author":"Yan","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib71","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/EJE-18-1000","article-title":"Mechanisms in endocrinology: Estradiol as a male hormone","volume":"181","author":"Russell","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-024-03817-0","article-title":"Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism","volume":"85","author":"Stumpf","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-09-0084","article-title":"Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment","volume":"161","author":"Ribeiro","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib74","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/JU.0000000000000396","article-title":"Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism","volume":"202","author":"Krzastek","year":"2019","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/andr.13146","article-title":"Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis","volume":"10","author":"Huijben","year":"2022","journal-title":"Andrology"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib76","first-page":"139","article-title":"Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women","volume":"50","author":"Forsbach","year":"1977","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.beem.2026.102081_bib77","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.1978.tb14949.x","article-title":"Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea","volume":"85","author":"McGarrigle","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)44178-6","article-title":"Induction of ovulation in women with hyperprolactinemic amenorrhea using clomiphene and human chorionic gonadotropin of bromocriptine","volume":"32","author":"Radwanska","year":"1979","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.fertnstert.2019.09.020","article-title":"Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion","volume":"113","author":"Practice Committees of the American Society for Reproductive Medicine and Society for Reproductive Endocrinology and Infertility","year":"2020","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.beem.2026.102081_bib80","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jcem-12-8-985","article-title":"The effects of chorionic gonadotropin in adult men: increased estrogen and 17-ketosteroid excretion, gynecomastia, leydig cell stimulation and semi-niferous tubule damage","volume":"12","author":"Maddock","year":"1952","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12958-020-00639-3","article-title":"Influence of human chorionic gonadotrophin during ovarian stimulation: an overview","volume":"18","author":"Smitz","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib82","first-page":"133","article-title":"Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism","volume":"1540","author":"Dwyer","year":"2024","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib83","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/14647273.2013.829673","article-title":"British fertility society. british fertility society. 'Ovulation induction in WHO type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS policy and practice committee","volume":"16","author":"Yasmin","year":"2013","journal-title":"Hum Fertil"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib84","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2017.01.011","article-title":"Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis","volume":"107","author":"Green","year":"2017","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib85","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.15097","article-title":"Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism","volume":"101","author":"Jayasena","year":"2024","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib86","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s40618-023-02231-z","article-title":"Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review","volume":"47","author":"Z\u00fa\u00f1iga","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib87","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2009.02.066","article-title":"Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner","volume":"93","author":"Joo","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib88","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.fertnstert.2005.02.045","article-title":"Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry","volume":"84","author":"Soldin","year":"2005","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib89","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102081_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1055097","article-title":"The role of growth hormone in assisted reproduction","volume":"13","author":"Quaas","year":"2022","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib91","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2026.102081_bib92","article-title":"Growth hormone for in vitro fertilisation (IVF)","volume":"11","author":"Sood","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib93","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.fertnstert.2015.07.1132","article-title":"Pregnancy outcomes in women with growth hormone deficiency","volume":"104","author":"Vila","year":"2015","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.beem.2026.102081_bib94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/js.2017-00005","article-title":"Successful pregnancies after adequate hormonal replacement in patients with combined pituitary hormone deficiencies","volume":"1","author":"Correa","year":"2017","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11154-019-09530-y","article-title":"Fertility issues in aggressive pituitary tumors","volume":"21","author":"Marques","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib96","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-21-0462","article-title":"ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy","volume":"185","author":"Luger","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib97","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1210\/clinem\/dgae821","article-title":"Disease activity and maternal-fetal outcomes in pregnant women with prolactinoma: a systematic review and meta-analysis","volume":"110","author":"Bandeira","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2464","article-title":"Cabergoline use and pregnancy outcomes: a systematic review","volume":"117","author":"Otis","year":"2025","journal-title":"Birth Defects Res"},{"issue":"9","key":"10.1016\/j.beem.2026.102081_bib99","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","article-title":"Approach to the patient with prolactinoma","volume":"108","author":"Auriemma","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11102-019-01008-z","article-title":"A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas","volume":"23","author":"Sant' Anna","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102081_bib101","first-page":"452","article-title":"Women with prolactinoma--effect of pregnancy and lactation on serum prolactin and on tumour growth","volume":"111","author":"Holmgren","year":"1986"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(88)80346-2","article-title":"Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging","volume":"85","author":"Gonzalez","year":"1988","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ogc.2004.08.003","article-title":"Pituitary gland and pregnancy","volume":"31","author":"Foyouzi","year":"2004","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib104","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9378(77)90594-4","article-title":"Pattern of increase in circulating prolactin levels during human gestation","volume":"129","author":"Rigg","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib105","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1515\/cclm-2017-0644","article-title":"Serum prolactin levels across pregnancy and the establishment of reference intervals","volume":"56","author":"Hu","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib106","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","article-title":"Pituitary tumors in pregnancy","volume":"48","author":"Huang","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.beem.2026.102081_bib107","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0890-6238(96)00134-7","article-title":"Reproductive toxicity of cabergoline in mice, rats, and rabbits","volume":"10","author":"Beltrame","year":"1996","journal-title":"Reprod Toxicol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11102-005-5083-4","article-title":"Prolactinomas and pregnancy","volume":"8","author":"Bronstein","year":"2005","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib109","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib111","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12020-014-0334-7","article-title":"Prolactinomas, cabergoline, and pregnancy","volume":"47","author":"Glezer","year":"2014","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib112","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/09513590.2016.1254177","article-title":"Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy","volume":"33","author":"Rastogi","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AOG.0000000000001747","article-title":"Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes","volume":"129","author":"Lambert","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib114","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-014-3210-z","article-title":"Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database","volume":"290","author":"Hurault-Delarue","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.15304","article-title":"Safety of cabergoline for prolactinoma in pregnancy: a systematic review and meta-analysis","volume":"103","author":"Chakraborty","year":"2025","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1753495X15598917","article-title":"Pituitary apoplexy in pregnancy: a case series and literature review","volume":"8","author":"Grand'Maison","year":"2015","journal-title":"Obstet Med"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-21-0145","article-title":"Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature","volume":"185","author":"Kuhn","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102081_bib119","article-title":"Microprolactinoma growth during pregnancy with pituitary tumor apoplexy: case report and review of the literature","volume":"2025","author":"Introini","year":"2025","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102081_bib120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09513590.2019.1650339","article-title":"A case of atypical macroprolactinoma presenting with pituitary apoplexy during pregnancy and review of the literature","volume":"36","author":"Oguz","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102081_bib121","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jcem-38-3-413","article-title":"Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects","volume":"38","author":"Noel","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib122","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","article-title":"Relationship between the methods of treatment for prolactinomas and the puerperal lactation","volume":"47","author":"Ikegami","year":"1987","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib123","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib124","doi-asserted-by":"crossref","first-page":"423","DOI":"10.23736\/S0391-1977.17.02792-4","article-title":"Prolactinomas: how to handle prior to and during pregnancy?","volume":"43","author":"Glezer","year":"2018","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.beem.2026.102081_bib125","series-title":"Treatment of pituitary adenomas","first-page":"114","article-title":"PRL-secreting adenomas. A correlative study of morphological and clinical data","author":"Peillon","year":"1978"},{"issue":"5","key":"10.1016\/j.beem.2026.102081_bib126","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2015","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(72)90446-2","article-title":"Studies of prolactin secretion in human pregnancy","volume":"113","author":"Tyson","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.beem.2026.102081_bib128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2026.102081_bib129","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:18:58Z","timestamp":1788866338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521690X26000023"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102081","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility and pregnancy in patients with prolactinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102081"}}